Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PIAS2 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA518489
Description
This antibody is predicted to react with canine, mouse and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 8,000.
This gene encodes a protein involved in the regulation of transcription factors involved in MAP kinase signaling. The symbol MIZ1 has also been associated with ZBTB17 which is a different gene located on chromosome 1. Two alternatively spliced transcripts encoding different isoforms have been described.
Specifications
PIAS2 | |
Polyclonal | |
Unconjugated | |
Pias2 | |
6330408K17Rik; AI462206; androgen receptor-interacting protein 3; ARIP3; AU018068; DAB2-interacting protein; Dib; DIP; E3 SUMO-protein ligase PIAS2; E3 SUMO-protein transferase PIAS2; MGC102682; MIZ; Miz1; Msx-interacting zinc finger protein; Msx-interacting-zinc finger; msx-interacting-zinc finger protein; Pias2; PIAS-NY protein; Piasx; PIASxalpha; PIASX-ALPHA; PIASxalpha6; PIASxb; PIASxbeta; PIASX-BETA; protein inhibitor of activated STAT 2; protein inhibitor of activated STAT x; protein inhibitor of activated STAT, 2; Protein inhibitor of activated STAT2; RING-type E3 ubiquitin transferase PIAS2; SIZ2; zinc finger, MIZ-type containing 4; ZMIZ4 | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
9063 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
O75928 | |
Pias2 | |
Synthetic peptide sequence (KEAMKVSSQPCTKIE) corresponding to the internal amino acids of PIAS2 (aa 431-446). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction